Respiratory System — MCQs

Respiratory System Indian Medical PG Practice Questions and MCQs

Question 431: Early in an attack of asthma, which of the following sets of arterial blood values is most likely?

A. Normal PO2 and normal PCO2
B. Normal PO2 and low PCO2
C. Normal PO2 and elevated PCO2
D. Low PO2 and low PCO2 (Correct Answer)

Explanation: **Explanation:** The correct answer is **Low PO2 and low PCO2**. **1. Why it is correct:** During an acute asthma attack, bronchospasm and airway inflammation lead to **Ventilation-Perfusion (V/Q) mismatch**. Some areas of the lung are poorly ventilated but well-perfused, leading to a drop in arterial oxygen levels (**Hypoxemia/Low PO2**). In the **early stage**, the body compensates for this hypoxia through a reflex increase in the respiratory rate (tachypnea). Because Carbon Dioxide ($CO_2$) is highly diffusible (20 times more than $O_2$), this hyperventilation effectively "washes out" $CO_2$ from the blood, resulting in **Hypocapnia (Low PCO2)** and respiratory alkalosis. **2. Why the other options are incorrect:** * **Option A & B:** These are incorrect because even a mild asthma attack typically causes enough V/Q mismatch to lower the $PO_2$ below normal levels. * **Option C:** An elevated $PCO_2$ (Hypercapnia) is a **late and ominous sign** in asthma. It indicates that the patient’s respiratory muscles are fatiguing, and they can no longer maintain the high minute ventilation required to blow off $CO_2$. **3. NEET-PG High-Yield Pearls:** * **The "Normal" PCO2 Trap:** In a severe asthma attack, a "normal" $PCO_2$ value is a **danger sign**. It suggests the patient is transitioning from hyperventilation to respiratory failure. * **Acid-Base Status:** Early asthma presents with **Respiratory Alkalosis**; late/status asthmaticus presents with **Respiratory Acidosis**. * **A-a Gradient:** The Alveolar-arterial (A-a) oxygen gradient is typically **increased** in asthma due to V/Q mismatch.

Question 432: What will be the effect on respiration if a transaction is made between the pons and medulla?

A. Apnea
B. Irregular and gasping (Correct Answer)
C. No effect
D. Slow and deep

Explanation: ### Explanation The control of respiration is governed by the respiratory centers located in the brainstem. To understand the effect of a transection between the **pons and medulla**, one must look at the hierarchy of these centers: 1. **Medullary Centers:** The Dorsal Respiratory Group (DRG) and Ventral Respiratory Group (VRG) are the primary rhythm generators. 2. **Pontine Centers:** The Pneumotaxic and Apneustic centers modulate the medullary rhythm to ensure smooth, regular breathing. **Why "Irregular and Gasping" is correct:** When a transection occurs at the **ponto-medullary junction**, the medulla is isolated from all higher pontine influences. While the medulla can generate a basic rhythm independently, it is inherently unstable and uncoordinated. This results in an **ataxic breathing pattern**, characterized by irregular, jerky, and gasping breaths. **Analysis of Incorrect Options:** * **Apnea (A):** This occurs only if the transection is **below the medulla** (at or below C3-C5), which severs the connection to the phrenic nerve and diaphragm. * **No effect (C):** Incorrect, as the pontine centers are essential for the "fine-tuning" and regularity of the respiratory cycle. * **Slow and deep (D):** This pattern (Apneustic breathing) occurs if there is a transection in the **mid-pons** combined with a bilateral **Vagus nerve** injury, which removes the "off-switch" for inspiration. ### High-Yield Clinical Pearls for NEET-PG * **Pneumotaxic Center (Upper Pons):** Its primary function is to limit inspiration (the "off-switch"), thereby increasing respiratory rate. * **Apneustic Center (Lower Pons):** Promotes deep, prolonged inspiration. * **Vagus Nerve (CN X):** Carries inhibitory signals from pulmonary stretch receptors (Hering-Breuer Reflex). If the Vagus is cut, breathing becomes slower and deeper. * **Sectioning Summary:** * Above Pons: Normal breathing (if Vagus intact). * Mid-Pons + Vagus cut: Apneustic breathing. * Ponto-medullary junction: Irregular/Gasping. * Below Medulla: Death/Apnea.

Question 433: What happens in decreased lung compliance?

A. Increased respiratory rate and decreased tidal volume (Correct Answer)
B. Increased respiratory rate and increased tidal volume
C. Decreased respiratory rate and increased tidal volume
D. Decreased respiratory rate and decreased tidal volume

Explanation: **Explanation:** The core concept behind this question is the **Work of Breathing (WOB)**. In conditions with **decreased lung compliance** (e.g., Pulmonary Fibrosis, ARDS, or Pulmonary Edema), the lungs become "stiff." To expand these stiff lungs, the body must overcome significant **elastic resistance**. 1. **Why Option A is correct:** To minimize the energy expenditure (WOB), the body adopts a **Rapid Shallow Breathing Pattern**. * **Decreased Tidal Volume ($V_T$):** Taking a deep breath requires significant pressure to stretch stiff elastic fibers. By decreasing $V_T$, the elastic work is minimized. * **Increased Respiratory Rate (RR):** To maintain adequate **Minute Ventilation** ($\text{RR} \times V_T$) and prevent hypercapnia, the body compensates for the low $V_T$ by increasing the frequency of breaths. 2. **Why other options are incorrect:** * **Options B & C:** Increasing Tidal Volume in a non-compliant lung would exponentially increase the elastic work of breathing, leading to rapid respiratory muscle fatigue. * **Options C & D:** Decreasing the respiratory rate alongside a low or high $V_T$ would result in inadequate alveolar ventilation, leading to respiratory failure. **NEET-PG High-Yield Pearls:** * **Elastic Work:** Increased in restrictive diseases (decreased compliance). Minimized by rapid, shallow breathing. * **Non-Elastic (Airway) Work:** Increased in obstructive diseases (e.g., Asthma, COPD). Minimized by **slow, deep breathing** (Decreased RR, Increased $V_T$). * **Compliance Formula:** $C = \Delta V / \Delta P$. In fibrosis, the slope of the Pressure-Volume curve shifts to the **right and downwards**. * **Total Work of Breathing:** Normally represents only ~5% of total oxygen consumption but can increase significantly in disease states.

Question 434: Anatomic dead space in a non-smoker under normal conditions is:

A. 2.2 cc/kg (Correct Answer)
B. 5.1 cc/kg
C. 3.1 cc/kg
D. 1.5 cc/kg

Explanation: ### Explanation **1. Understanding the Correct Answer (Option A: 2.2 cc/kg)** Anatomic dead space refers to the volume of the conducting airways (from the nose/mouth down to the terminal bronchioles) where no gas exchange occurs because there are no alveoli. In a healthy, non-smoking adult, the anatomic dead space is roughly proportional to body size. The standard physiological estimate is **2.2 mL per kg (or 1 mL per pound)** of ideal body weight. For an average 70 kg adult, this equates to approximately **150 mL**. This volume is essential for warming and humidifying inspired air but does not contribute to the respiratory zone. **2. Analysis of Incorrect Options** * **Option B (5.1 cc/kg):** This value is significantly higher than physiological norms. Such a high dead space would imply severe pathological conditions or massive over-inflation of conducting zones, leading to inefficient ventilation. * **Option C (3.1 cc/kg):** While closer, this exceeds the standard 2.2 cc/kg ratio. It might be seen in specific clinical scenarios involving high PEEP (Positive End-Expiratory Pressure) or large instrumental dead space (e.g., long ventilator tubings), but it is not the "normal" value. * **Option D (1.5 cc/kg):** This value is too low for an adult. While children have a slightly different ratio, 2.2 cc/kg remains the standard benchmark for medical examinations. **3. NEET-PG High-Yield Pearls** * **Fowler’s Method:** Used to measure **Anatomic Dead Space** using single-breath nitrogen washout. * **Bohr’s Equation:** Used to measure **Physiological Dead Space** using arterial and expired $CO_2$ levels. * **Physiological vs. Anatomic:** In healthy individuals, Anatomic Dead Space $\approx$ Physiological Dead Space. In lung diseases (like COPD), Physiological Dead Space increases because of "Alveolar Dead Space" (ventilated but non-perfused alveoli). * **Positioning:** Dead space is higher when standing than when supine.

Question 435: Which of the following physiological conditions will lead to pulmonary vasodilation?

A. Hypercapnia
B. Decreased PaCO2
C. Baroreceptor stimulation (Correct Answer)
D. Chemoreceptor stimulation

Explanation: **Explanation:** The pulmonary circulation is unique because its primary function is gas exchange, and its vascular resistance is regulated differently compared to the systemic circulation. **1. Why Baroreceptor Stimulation is Correct:** The pulmonary vasculature is innervated by the autonomic nervous system. Stimulation of the **arterial baroreceptors** (located in the carotid sinus and aortic arch) in response to high systemic blood pressure triggers a reflex that increases parasympathetic activity and decreases sympathetic tone. This leads to **pulmonary vasodilation**, helping to accommodate volume and prevent pulmonary hypertension. **2. Why the Other Options are Incorrect:** * **Hypercapnia (A) and Chemoreceptor Stimulation (D):** In the lungs, hypercapnia (high $CO_2$) and acidosis (often sensed by chemoreceptors) act as potent **vasoconstrictors**. This is part of the body’s mechanism to divert blood flow away from poorly ventilated areas (where $CO_2$ is high) toward better-ventilated areas to optimize gas exchange. * **Decreased $PaCO_2$ (B):** While hypocapnia (low $CO_2$) generally causes vasodilation in the systemic and cerebral circulation, its effect on the pulmonary vasculature is relatively weak compared to the profound **Hypoxic Pulmonary Vasoconstriction (HPV)** triggered by low $O_2$. **Clinical Pearls for NEET-PG:** * **Hypoxic Pulmonary Vasoconstriction (HPV):** This is the most important local control mechanism. Unlike systemic vessels (which dilate during hypoxia), pulmonary vessels **constrict** in response to low alveolar $PO_2$. * **Nitric Oxide (NO):** The most potent endogenous pulmonary vasodilator; often used therapeutically in persistent pulmonary hypertension of the newborn (PPHN). * **Zone of West:** Remember that pulmonary vascular resistance is lowest at **Functional Residual Capacity (FRC)**.

Question 436: At which point is the concentration of CO2 the least?

A. Anatomical dead space at the end of inspiration (Correct Answer)
B. Anatomical dead space at the end of expiration
C. Alveoli at the end of inspiration
D. Alveoli at the end of expiration

Explanation: **Explanation:** The concentration of $CO_2$ in the respiratory tract is determined by the mixing of atmospheric air (which contains negligible $CO_2$, approx. 0.04%) and alveolar air (which is rich in $CO_2$, approx. 5-6% or 40 mmHg). **1. Why Option A is Correct:** During **inspiration**, we inhale atmospheric air. By the **end of inspiration**, the anatomical dead space (conducting zone) is completely filled with this fresh atmospheric air that has not yet reached the alveoli for gas exchange. Therefore, the $CO_2$ concentration here is at its absolute minimum (virtually zero). **2. Why the other options are incorrect:** * **Option B (Dead space at end-expiration):** During expiration, $CO_2$-rich air from the alveoli travels out through the dead space. At the end of expiration, the dead space remains filled with this "stale" alveolar air. This is why the first portion of the next inspiration contains high $CO_2$. * **Option C (Alveoli at end-inspiration):** Even at the end of inspiration, the alveoli always contain a functional residual capacity (FRC) of air. The fresh air mixes with existing $CO_2$-rich air; thus, $CO_2$ is diluted but never zero. * **Option D (Alveoli at end-expiration):** This point represents the **highest** concentration of $CO_2$ in the lungs, as $CO_2$ has been diffusing from the blood into the alveoli throughout the respiratory cycle without being diluted by fresh air. **High-Yield Clinical Pearls for NEET-PG:** * **Anatomical Dead Space:** Volume of the conducting zone (~150 ml). It is measured by **Fowler’s Method** (Nitrogen washout). * **Physiological Dead Space:** Anatomical dead space + Alveolar dead space. It is measured by **Bohr’s Equation** (using $PeCO_2$). * In healthy individuals, anatomical and physiological dead spaces are nearly equal. * The first air expired is from the dead space ($CO_2$ = 0); the last air expired is pure alveolar air (End-tidal $CO_2$).

Question 437: Which of the following is a neuroendocrine function of the lungs?

A. Erythropoietin secretion
B. Angiotensin conversion (Correct Answer)
C. Surfactant manufacture
D. Fibrinolytic substance secretion

Explanation: The lungs are not just organs for gas exchange; they also function as a vital metabolic and endocrine site. ### **Explanation of the Correct Answer** **Option B (Angiotensin conversion)** is the correct answer because the pulmonary capillary endothelium contains high concentrations of **Angiotensin-Converting Enzyme (ACE)**. This enzyme is responsible for converting **Angiotensin I** (decapeptide) into **Angiotensin II** (octapeptide), a potent vasoconstrictor. This conversion is a key step in the Renin-Angiotensin-Aldosterone System (RAAS), which regulates systemic blood pressure and fluid balance. ### **Analysis of Incorrect Options** * **Option A (Erythropoietin secretion):** Erythropoietin is primarily secreted by the **peritubular interstitial cells of the kidney** (85%) and the liver (15%) in response to hypoxia. The lungs do not produce this hormone. * **Option C (Surfactant manufacture):** While this is a vital lung function performed by **Type II Alveolar cells (Pneumocytes)**, it is considered a **secretory/exocrine** function rather than a neuroendocrine one. Surfactant reduces surface tension to prevent alveolar collapse. * **Option D (Fibrinolytic substance secretion):** The lungs do produce substances like plasminogen activator to dissolve small clots, but this is categorized under the **hematologic/protective** function of the pulmonary endothelium, not neuroendocrine signaling. ### **High-Yield NEET-PG Pearls** * **Metabolic Inactivation:** The lungs are responsible for the inactivation of **Bradykinin** (via ACE), **Serotonin**, and **Prostaglandins (E1, E2, F2α)**. * **Substances NOT cleared by lungs:** Epinephrine, Dopamine, and Angiotensin II pass through the pulmonary circulation unchanged. * **Kulchitsky Cells:** These are the actual neuroendocrine cells of the lung (Small Granular Cells). They are the cells of origin for **Small Cell Carcinoma** and **Carcinoid tumors**.

Question 438: In COPD, which of the following statements is true?

A. FEV1/FVC < 0.7 (Correct Answer)
B. FEV1/FVC > 0.7
C. RV is decreased
D. TLC is decreased

Explanation: **Explanation:** Chronic Obstructive Pulmonary Disease (COPD) is characterized by persistent airflow limitation. The physiological hallmark of obstructive lung diseases is an increased resistance to airflow, particularly during expiration. **1. Why Option A is Correct:** In COPD, the **Forced Expiratory Volume in 1 second (FEV1)** decreases significantly more than the **Forced Vital Capacity (FVC)** due to airway narrowing and loss of elastic recoil. According to GOLD guidelines, a post-bronchodilator **FEV1/FVC ratio of < 0.70** is the diagnostic criterion for airflow obstruction. This indicates that the patient cannot exhale a normal portion of their total lung air in the first second. **2. Why the other options are incorrect:** * **Option B:** An FEV1/FVC ratio > 0.7 is seen in normal individuals or patients with **Restrictive Lung Diseases** (where both FEV1 and FVC decrease proportionately, or FVC decreases more). * **Option C & D:** In COPD, air becomes trapped in the distal airspaces (air-trapping). This leads to **Hyperinflation**, which causes an **increase** in **Residual Volume (RV)**, Functional Residual Capacity (FRC), and **Total Lung Capacity (TLC)**. Decreased RV and TLC are characteristic features of restrictive diseases like Interstitial Lung Disease (ILD). **High-Yield Clinical Pearls for NEET-PG:** * **Flow-Volume Loop:** In COPD, the expiratory limb shows a characteristic **"scooped-out" appearance**. * **Diffusion Capacity (DLCO):** Decreased in Emphysema (due to alveolar destruction) but typically normal in Chronic Bronchitis. * **Compliance:** Lung compliance is **increased** in emphysema due to the loss of elastic fibers.

Question 439: Spirometry cannot measure which of the following?

A. Residual Volume (RV) (Correct Answer)
B. Tidal Volume (TV)
C. Inspiratory Reserve Volume (IRV)
D. Expiratory Reserve Volume (ERV)

Explanation: **Explanation:** Spirometry is a gold-standard pulmonary function test that measures the volume of air an individual can inhale or exhale as a function of time. However, it has a fundamental limitation: **it can only measure air that moves in and out of the lungs.** **Why Residual Volume (RV) is the correct answer:** Residual Volume is defined as the volume of air remaining in the lungs after a maximal forced expiration. Since this air never leaves the respiratory tract during normal or forced breathing maneuvers, a spirometer cannot "see" or measure it. Consequently, any lung capacity that includes RV—such as **Functional Residual Capacity (FRC)** and **Total Lung Capacity (TLC)**—also cannot be measured by simple spirometry. These require specialized techniques like Helium Dilution, Nitrogen Washout, or Body Plethysmography. **Why the other options are incorrect:** * **Tidal Volume (TV):** This is the volume of air inspired or expired during a normal resting breath. Since it involves active air movement, it is easily recorded. * **Inspiratory Reserve Volume (IRV):** This is the extra volume of air that can be inspired over and above the normal tidal volume. * **Expiratory Reserve Volume (ERV):** This is the extra volume of air that can be expired by forceful exertion after the end of a normal tidal expiration. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** Spirometry cannot measure **"FRV"** (FRC, RV, and TLC). * **Vital Capacity (VC):** The maximum volume of air a person can expel from the lungs after maximum inhalation (VC = TV + IRV + ERV). It is the largest volume measurable by spirometry. * **Body Plethysmography:** This is the most accurate method to measure RV as it follows Boyle’s Law ($P_1V_1 = P_2V_2$) and accounts for trapped air in the thorax.

Question 440: Total lung capacity is dependent on which of the following?

A. Size of airway
B. Closing tidal volume
C. Lung compliance (Correct Answer)
D. Residual volume

Explanation: **Explanation:** **Total Lung Capacity (TLC)** is the maximum volume of air the lungs can hold after a maximal inspiratory effort. It is determined by the balance between the strength of the inspiratory muscles and the inward elastic recoil of the lungs. **Why Lung Compliance is Correct:** Compliance refers to the "distensibility" or the ease with which the lungs expand. TLC is directly dependent on lung compliance. In restrictive lung diseases (e.g., Pulmonary Fibrosis), compliance decreases, making the lungs "stiff" and reducing TLC. Conversely, in obstructive diseases like Emphysema, compliance increases due to the loss of elastic tissue, leading to hyperinflation and an increased TLC. **Analysis of Incorrect Options:** * **Size of Airway:** This primarily affects airway resistance and flow rates (like FEV1), not the total volume the lung can hold. * **Closing Tidal Volume:** This relates to the point during expiration when small airways in the dependent parts of the lung begin to close; it does not determine the maximum capacity of the lungs. * **Residual Volume (RV):** While RV is a component of TLC (TLC = VC + RV), it is a volume, not a physiological determinant. TLC is the independent variable that dictates the limits of other volumes based on the lung's physical properties. **High-Yield Clinical Pearls for NEET-PG:** * **TLC Formula:** TLC = Vital Capacity (VC) + Residual Volume (RV). * **Measurement:** TLC cannot be measured by simple spirometry (because it includes RV); it requires **Body Plethysmography** or Helium Dilution. * **Compliance Equation:** Compliance (C) = ΔV / ΔP. * **Surfactant:** Increases compliance by reducing surface tension, thereby preventing the collapse of alveoli and supporting TLC.

Practice by Chapter

Mechanics of Breathing

Practice Questions

Pulmonary Ventilation

Practice Questions

Pulmonary Circulation

Practice Questions

Gas Exchange in the Lungs

Practice Questions

Oxygen and Carbon Dioxide Transport

Practice Questions

Control of Breathing

Practice Questions

Respiratory Adjustments in Health and Disease

Practice Questions

High Altitude Physiology

Practice Questions

Diving Physiology

Practice Questions

Respiratory Function Tests

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free